Two Sigma Advisers
VTVT icon

Two Sigma Advisers’s vTv Therapeutics VTVT Stock Holding History

Two Sigma Advisers’s Portfolio VTVT Stock Details VTVT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q3 		– Sell
-1,058
Closed -$96K – 2694
2021
Q2 		$96K Sell
1,058
-3,905
-79% -$396K ﹤0.01% 2348
2021
Q1 		$560K Buy
4,963
+3,790
+323% +$372K ﹤0.01% 1966
2020
Q4 		$87K Sell
1,173
-10,812
-90% -$829K ﹤0.01% 2282
2020
Q3 		$849K Buy
11,985
+7,887
+192% +$693K ﹤0.01% 1572
2020
Q2 		$369K Buy
4,098
+3,150
+332% +$311K ﹤0.01% 2029
2020
Q1 		$72K Buy
+948
New +$91.2K ﹤0.01% 2345

Other funds holding VTVT

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
WAG
Winthrop Advisory Group Boston, Massachusetts $1.48B AUM 22.62% 1-Year Est. Return
CIM
CIM Investment Management Pittsburgh, Pennsylvania $375M AUM 32.03% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return
GCP
GSA Capital Partners London, United Kingdom $1.61B AUM 28.28% 1-Year Est. Return
VF
Virtu Financial New York $2.41B AUM 48.35% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vontobel Holding
Vontobel Holding Zurich, Switzerland $29.1B AUM 22.79% 1-Year Est. Return

Two Sigma Advisers's VTVT Position: Q3 2021 in Review

Two Sigma Advisers sold out of vTv Therapeutics (VTVT) in Q3 2021, closing a stake of 1,058 shares — an estimated $96K sold.

Two Sigma Advisers first reported a position in VTVT in Q1 2020 and held it in 6 quarters. The position peaked at $849K in Q3 2020. 31 funds tracked by Wall St. Rank hold VTVT as of Q3 2021.

  • Two Sigma Advisers reported no remaining vTv Therapeutics position as of Q3 2021 after selling out during the quarter.
  • Two Sigma Advisers sold 1,058 vTv Therapeutics shares in Q3 2021, an estimated $96K.
  • Two Sigma Advisers first reported a position in vTv Therapeutics in Q1 2020 and held it in 6 quarters.
  • Two Sigma Advisers's vTv Therapeutics position peaked at $849K in Q3 2020.
  • 31 funds tracked by Wall St. Rank held vTv Therapeutics as of Q3 2021.

Based on Two Sigma Advisers's 13F filing for Q3 2021, filed 15 Nov 2021.